Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients
Open Access
- 31 May 2005
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 149 (5), 820-825
- https://doi.org/10.1016/j.ahj.2004.07.023
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Analysis of the Relationship between Norepinephrine and Asymmetric Dimethyl Arginine Levels among Patients with End-Stage Renal DiseaseJournal of the American Society of Nephrology, 2004
- Acetylcysteine Reduces Plasma Homocysteine Concentration and Improves Pulse Pressure and Endothelial Function in Patients With End-Stage Renal FailureCirculation, 2004
- Small Apolipoprotein(a) Size Predicts Mortality in End-Stage Renal DiseaseCirculation, 2002
- Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patientsKidney International, 2002
- Inflammation and cardiovascular risk in dialysis patientsKidney International, 2002
- HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patientsKidney International, 2002
- Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients*Nephrology Dialysis Transplantation, 1999
- Histological diagnosis of renal osteodystrophyKidney International, 1999
- C-reactive protein as an outcome predictor for maintenance hemodialysis patientsKidney International, 1998
- Quantification of coronary artery calcium using ultrafast computed tomographyJournal of the American College of Cardiology, 1990